CC Tea has signed three-year anti-cancer research collaboration to assess the efficacy of CC Tea extract on molecular pathways in lymphocytes and other blood cells of cancer patients of North-East India. The three phased research undertaking will begin with CC Tea extract tested on blood cells taken from cancer patients to concluding with the product being tested on patients directly.
According to the report, Mizoram and Arunachal Pradesh recorded the highest incidence of new cancer cases in the country among females and males respectively. The company recently concluded a 6 months anti-viral and immune modulatory research with the prestigious Indian Institute of Technology, Guwahati and have found that CC Tea showed high anti-viral activity to the Japanese Encephalitis Virus (JEV) and Newcastle Disease Virus (NDV). It also suggests positive innate immune activation in gene analysis. RageshKeisham, Chairman & CEO of SuiGeneris Agronomy Private Limited said, “A recent Govt. study finds that North East is the cancer capital of India and this research collaboration with Dr.BBarooah Cancer Institute, Guwahati is a proof of our commitment for a relentless fight against Cancer.”
CC Tea inks anti-cancer research collaboration with Dr B Barooah Cancer Institute
